The Cost-effectiveness of a Point-of-Care Paper Transaminase Test for Monitoring Treatment of HIV/TB Co-Infected Persons

Keyphrases

• Cost-effectiveness 100%
• Point-of-care 100%
• Treatment Monitoring 100%
• Transaminases 100%
• Paper-based Test 100%
• HIV-tuberculosis 100%
• Automated Testing 50%
• South Africa 33%
• Incremental Cost-effectiveness Ratio 33%
• Quality-adjusted Life Years 33%
• Paper-based 33%
• Laboratory Monitoring 33%
• Clinical Monitoring 33%
• Drug-induced Liver Injury 33%
• Three-class Classification 33%
• Antiretroviral Therapy 16%
• People Living with HIV (PLHIV) 16%
• Validation Studies 16%
• Tuberculosis Treatment 16%
• Observational Cohort 16%
• Decision-analytic Model 16%
• Hepatotoxic 16%
• Long-term Clinical Outcome 16%
• Current Performance 16%
• Probabilistic Sensitivity Analysis 16%
• Finger Prick 16%
• Placement Strategy 16%
• Tuberculosis Coinfection 16%
• Injury Monitoring 16%

Nursing and Health Professions

• Cost Effectiveness Analysis 100%
• Aminotransferase 100%
• Human Immunodeficiency Virus 100%
• Patient Monitoring 100%
• Quality Adjusted Life Year 50%
• Incremental Cost-Effectiveness Ratio 50%
• South Africa 50%
• Toxic Hepatitis 50%
• Clinical Outcome 25%
• Antiretroviral Therapy 25%
• Liver Toxicity 25%
• Mixed Infection 25%
• Validation Study 25%

Medicine and Dentistry

• Health Care Cost 100%
• Cost-Effectiveness Analysis 100%
• Human Immunodeficiency Virus 100%
• Patient Monitoring 100%
• Transaminase 100%
• Quality Adjusted Life Year 50%
• Toxic Hepatitis 50%
• Antiretroviral Therapy 25%
• Liver Toxicity 25%
• Mixed Infection 25%